636 results on '"Kahlmeter, Gunnar"'
Search Results
52. Re: In the name of common sense: EUCAST breakpoints and potential pitfalls. National dissemination of EUCAST guidelines is a shared responsibility
53. Selective reporting of antibiotic susceptibility testing results: less is more
54. The 2014 Garrod Lecture: EUCAST – are we heading towards international agreement?
55. Reviving old antibiotics
56. Multicentre testing of the EUCAST broth microdilution reference method for MIC determination on Mycobacterium tuberculosis
57. How to:perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by Trichophyton
58. Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis/Remise en question d'un dogme: points de rupture des tests de sensibilite aux antimicrobiens de la Mycobacterium tuberculosis/Desafiar un dogma: valores limite en pruebas de sensibilidad antimicrobiana para Mycobacterium tuberculosis
59. What is the role of the EUCAST reference method for MIC testing of the Mycobacterium tuberculosis complex?
60. White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the animal sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks
61. EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: Validation in 55 european laboratories
62. Multicentre testing of the EUCAST broth microdilution reference method for MIC determination on Mycobacterium tuberculosis
63. Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: the COMBACTE-Magnet EPI-Net COACH project
64. EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: validation in 55 European laboratories
65. Employing MIC data for mink pathogens to propose tentative epidemiological cut-off values: a step towards rationalizing antimicrobial use in mink
66. Employing MIC Data for Mink Pathogens to Propose Tentative Epidemiological Cut-Off Values:A Step Toward Rationalizing Antimicrobial Use in Mink
67. High genetic diversity of nitrofurantoin- or mecillinam-resistant Escherichia coli indicates low propensity for clonal spread
68. Living with extended-spectrum β-lactamase: A qualitative study of patient experiences
69. Laboratory control of antimicrobial therapy
70. List of Contributors
71. Sequence types and plasmid carriage of uropathogenic Escherichia coli devoid of phenotypically detectable resistance
72. Antimicrobial susceptibility to parenteral and oral agents in a largely polyclonal collection of CTX-M-14 and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae
73. Employing MIC Data for Mink Pathogens to Propose Tentative Epidemiological Cut-Off Values: A Step Toward Rationalizing Antimicrobial Use in Mink
74. Antimicrobial susceptibility of Corynebacterium diphtheriae and Corynebacterium ulcerans in Germany 2011–17
75. Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing Position Statements on Polymyxin B and Colistin Clinical Breakpoints
76. The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles
77. Applying Pharmacodynamics for Susceptibility Breakpoint Selection and Susceptibility Testing
78. Reply from Kahlmeter and Giske to Brecher, ‘EUCAST and CLSI Point-Counterpoint on Susceptibility Breakpoints: Do Two “I Agree”s Miss the Point?’
79. Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis
80. ‘Pre-emptive culturing’ will improve the chance of ‘getting it right’ when empirical therapy of urinary tract infections fails
81. Comment on: Redefining extended-spectrum β-lactamases: balancing science and clinical need
82. Redefining extended-spectrum β-lactamases: balancing science and clinical need
83. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli
84. Trimethoprim and enterococci in urinary tract infections: new perspectives on an old issue
85. Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016
86. Developmental roadmap for antimicrobial susceptibility testing systems
87. Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use
88. Effect of excluding duplicate isolates of Escherichia coli and Staphylococcus aureus in a 14 year consecutive database
89. Developments in the recent past---hospital hygiene and antimicrobials: Medical microbiology: a tool in control of health-care-associated infections
90. The role of horizontal gene transfer in the spread of trimethoprim–sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada
91. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria
92. Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO·SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections
93. Antibiotic Resistance Among Campylobacter jejuni/coli Strains Acquired in Sweden and Abroad: A Longitudinal Study
94. Resistance surveillance studies—comparability of results and quality assurance of methods
95. Dissemination of multidrug-resistant bacteria into the Arctic
96. Performance of a new EUCAST disk diffusion method using fastidious anaerobe agar (FAA) for clinical Bacteroides fragilis group isolates
97. Point-Counterpoint: Differences between the European Committee on Antimicrobial Susceptibility Testing and Clinical and Laboratory Standards Institute Recommendations for Reporting Antimicrobial Susceptibility Results
98. The proposed Drug Resistance Index (DRI) is not a good measure of antibiotic effectiveness in relation to drug resistance
99. Antibiotics for Ceftriaxone-Resistant Gram-Negative Bacterial Bloodstream Infections
100. Epidemiology of fungaemia and fungal meningitis in Sweden : a nationwide retrospective observational survey from sept 2015-aug 2016
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.